Biomedical Engineering Reference
In-Depth Information
[24] R. Miller, Z. Guo, E.A. Vogler, C.A. Siedlecki, Plasma coagulation response to surfaces with nanoscale
chemical heterogeneity, Biomaterials 27 (2006) 208
215.
[25] T. Sawase, et al., Photo-induced hydrophilicity enhances initial cell behavior and early bone apposition,
Clin. Oral Implants Res. 19 (2008) 491
496.
[26] G. Balasundaram, M. Sato, T.J. Webster, Using hydroxyapatite nanoparticles and decreased crystallinity
to promote osteoblast adhesion similar
to functionalizing with RGD, Biomaterials 27 (2006)
2798
2805.
[27] G. Weibrich, T. Hansen, W. Kleis, R. Buch, W.E. Hitzler, Effect of platelet concentration in platelet-rich
plasma on peri-implant bone regeneration, Bone 34 (2004) 665
671.
[28] W. Richter, Mesenchymal stem cells and cartilage in situ regeneration, J. Intern. Med. 266 (2009)
390
405.
[29] T.E. Ichim, et al., Mesenchymal stem cells as anti-inflammatories:
implications for treatment of
Duchenne muscular dystrophy, Cell. Immunol. 260 (2010) 75
82.
[30] A.J. Friedenstein, K.V. Petrakova, A.I. Kurolesova, G.P. Frolova, Heterotopic of bone marrow. Analysis
of precursor cells for osteogenic and hematopoietic tissues, Transplantation 6 (1968) 230
247.
[31] A.C.W. Zannettino, et al., Multipotential human adipose-derived stromal stem cells exhibit a perivascu-
lar phenotype in vitro and in vivo, J. Cell. Physiol. 214 (2008) 413
421.
[32] M.Q. Wickham, G.R. Erickson, J.M. Gimble, T.P. Vail, F. Guilak, Multipotent stromal cells derived
from the infrapatellar fat pad of the knee, Clin. Orthop. Relat. Res.
(2003) 196
212, doi:10.1097/01.
blo.0000072467.53786.ca.
[33] M.J. Hoogduijn, et al., Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have
immunomodulatory capacities, Stem Cells Dev. 16 (2007) 597
604.
[34] Y.-Y. Jo, et al., Isolation and characterization of postnatal stem cells from human dental tissues, Tissue
Eng. 13 (2007) 767
773.
[35] Q. He, C. Wan, G. Li, Concise review: multipotent mesenchymal stromal cells in blood, Stem Cells 25
(2007) 69
77.
[36] W. Oh, D.-S. Kim, Y.S. Yang, J.K. Lee, Immunological properties of umbilical cord blood-derived
mesenchymal stromal cells, Cell. Immunol. 251 (2008) 116
123.
[37] D.L. Morganstein, et al., Human fetal mesenchymal stem cells differentiate into brown and white adipo-
cytes: a role for ERRalpha in human UCP1 expression, Cell Res. 20 (2010) 434
444.
[38] L. Marinucci, et al., Effects of hydroxyapatite and Biostite
s
on osteogenic induction of hMSC, Ann.
Biomed. Eng. 38 (2010) 640
648.
[39] G. Lepski, et al., Limited Ca
2
1
and PKA-pathway dependent neurogenic differentiation of human
adult mesenchymal stem cells as compared to fetal neuronal stem cells, Exp. Cell Res. 316 (2010)
216
231.
[40] A.J. Engler, S. Sen, H.L. Sweeney, D.E. Discher, Matrix elasticity directs stem cell lineage specification,
Cell 126 (2006) 677
689.
[41] Y. Liu, et al., Flk-1
1
adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite
cells and ameliorate muscular dystrophy in mdx mice, Stem Cells Dev. 16 (2007) 695
706.
[42] M. Chivu, et al., In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under
differential exposure to liver-specific factors, Transl. Res. 154 (2009) 122
132.
[43] H. Agis, B. Kandler, M.B. Fischer, G. Watzek, R. Gruber, Activated platelets increase fibrinolysis of
mesenchymal progenitor cells, J. Orthop. Res. 27 (2009) 972
980.
[44] J.P. Vogel, et al., Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains
differentiation capacity and in vivo bone formation in calcium phosphate ceramics, Platelets 17 (2006)
462
469.
[45] Y. Mishima, M. Lotz, Chemotaxis of human articular chondrocytes and mesenchymal stem cells,
J. Orthop. Res. 26 (2008) 1407
1412.
